Lamictal
Nov 07, 2009 at 10:39 | Source: Business Line
Related News »
Even as UCB’s Keppra Captures the Largest Patient Share, Followed by GSK’s Lamictal, Strong Company Support and Positive Efficacy Performance Drive Uptake of UCB’s Vimpat in the Epilepsy Market, According to a Recent BioTrends Report ...
May 16, 2012 at 14:05 | Source: Bloomberg
He sometimes tamps down his freakouts, as well as what he calls his “mild bipolarity,” with “a morning cocktail of Klonopin, Effexor, Wellbutrin and Lamictal that my wife Lisa makes sure I have taken, terrified of medicated-less consequences.”
May 14, 2012 at 22:00 | Source: New York Times





